AIM
ABMD

Alhambra Investment Management’s Abiomed Inc ABMD Stock Holding History

Alhambra Investment Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,000
Closed -$246K – 152
2022
Q3 		$246K Hold
1,000
– – 0.19% 120
2022
Q2 		$248K Hold
1,000
– – 0.18% 127
2022
Q1 		$331K Hold
1,000
– – 0.22% 117
2021
Q4 		$359K Hold
1,000
– – 0.25% 110
2021
Q3 		$326K Hold
1,000
– – 0.25% 114
2021
Q2 		$312K Hold
1,000
– – 0.23% 115
2021
Q1 		$319K Buy
+1,000
New +$320K 0.26% 109

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $537M AUM 18.24% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Alhambra Investment Management's ABMD Position: Q4 2022 in Review

Alhambra Investment Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 1,000 shares — an estimated $246K sold.

Alhambra Investment Management first reported a position in ABMD in Q1 2021 and held it in 7 quarters. The position peaked at $359K in Q4 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Alhambra Investment Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Alhambra Investment Management sold 1,000 Abiomed Inc shares in Q4 2022, an estimated $246K.
  • Alhambra Investment Management first reported a position in Abiomed Inc in Q1 2021 and held it in 7 quarters.
  • Alhambra Investment Management's Abiomed Inc position peaked at $359K in Q4 2021.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Alhambra Investment Management's 13F filing for Q4 2022, filed 19 Jan 2023.